Christine Redmond Email & Phone Number

Boston, Ma, Us

Key member of the Ratio Senior Leadership Team responsible for the creation of the clinical development plans for development assets, including detailed budgets, resourcing, and detailed operational plans for a radio-labelled therapeutic in Oncology. Created an outsourcing strategy to cover all clinical development departments in support of Phase 1 & 2 trials. Created infrastructure (SOPs) and Quality Management System to support all programs. Responsible for Identification of vendors, engagement of vendors in the RFP process and vendor qualification. Wrote the clinical trial protocols and other key documents like Investigator Brochures. Oversee all of the contracting and fiscal management of the clinical programs as well as the planning and execution of the clinical trials.

Cambridge, Ma, Us

Portfolio Leader responsible for providing strategic leadership to Clinical Operations team members to ensure the successful execution of clinical trials in the tuberculosis vaccine/malaria/shigella portfolios. Primary point of accountability for GCO delivery of programs within assigned portfolio. Line manager for team of Clinical Operations Trial Leaders responsible for talent acquisition, on-boarding, performance management, and resource allocation.

Provided consulting services to biotech/pharma companies.

Cambridge, Ma, Us

Primary point of accountability for GCO delivery and communication to Biogen Disease Unit heads. Portfolio leader for >18 programs within the MS/Immunology and Therapeutics disease units. Key member of GCO Senior leadership team responsible for driving delivery within the portfolio. Line manager for (14) Clinical Operations Program Leaders (COPLs); responsible for talent acquisition, on-boarding, performance management, and resource allocation. Promoted to Senior Director in August 2020.

Cambridge, Ma, Us

Individual contributor and core member of the “Asset Team” responsible for setting strategy for life cycle management and label expansion of the asset. Leader of the Tecfidera® cross functional clinical development team (CDT) accountable for creation of the clinical development plans. Accountable for all aspects of the global program for Tecfidera® which included 30 global Phase I-IV studies, 1000 sites, 40 countries, and 12,000 patients.

Head of the Clinical Operations and Program Management department at a small Oncology Company, responsible for 25 staff. Led development and execution of the CDP for Ganetespib™. Led the Ganetespib™ program delivery comprised of 15 phase 1-3 studies.

Bedford, Massachusetts, Us

Head of the Clinical Operations department responsible for 35 staff and Flupridaz Program Leader accountable for the cross functional team and delivery for the phase 3 studies. Recipient of the President’s Award in 2012 for leadership on the Flurpiridaz Program.

Cambridge, Massachusetts, Us

Head of the department of 25 staff (including clinical operations, data management, medical writing, statistics). Led development and execution of the CDP for five oncology programs (diagnostics & therapeutics). Left due to instability cause by corporate bankruptcy.

Burlington, Ma, Us

Head of the Clinical Operations department responsible for a team of 30 clinical operations staff. Hired to complete the ongoing phase 3 trial in an accelerated timeline. Accountable for the execution of the clinical development plan for Kalbitor®. Implemented enrollment boosting activities resulting in a 140% increase in trial enrollment to complete Phase III pivotal trial in record time. Developed plan for project rescue as Battelle CRO went out of business in June 2008. Key member of team that submitted within 35 days phase 3 data readout.

Pearl River, New York, Us

Head of the department of 35 staff (including clinical operations, data management, medical writing, safety operations, regulatory operations, and quality assurance). Program leader overseeing programs in spinal cord injury & MS. Delivered the phase 3 trials leading to the approval of Ampyra®.

Bachelor Of Arts, Biology

Master Of Public Health (Mph), Epidemiology